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Abstract
Peroxisome proliferator-activated receptor-c (PPARc) is a master transcriptional regulator of adipogenesis. Hence, the
identification of PPARc coactivators should help reveal mechanisms controlling gene expression in adipose tissue
development and physiology. We show that the non-coding RNA, Steroid receptor RNA Activator (SRA), associates with
PPARc and coactivates PPARc-dependent reporter gene expression. Overexpression of SRA in ST2 mesenchymal precursor
cells promotes their differentiation into adipocytes. Conversely, knockdown of endogenous SRA inhibits 3T3-L1
preadipocyte differentiation. Microarray analysis reveals hundreds of SRA-responsive genes in adipocytes, including genes
involved in the cell cycle, and insulin and TNFa signaling pathways. Some functions of SRA may involve mechanisms other
than coactivation of PPARc. SRA in adipocytes increases both glucose uptake and phosphorylation of Akt and FOXO1 in
response to insulin. SRA promotes S-phase entry during mitotic clonal expansion, decreases expression of the cyclin-
dependent kinase inhibitors p21Cip1 and p27Kip1, and increases phosphorylation of Cdk1/Cdc2. SRA also inhibits the
expression of adipocyte-related inflammatory genes and TNFa-induced phosphorylation of c-Jun NH2-terminal kinase. In
conclusion, SRA enhances adipogenesis and adipocyte function through multiple pathways.
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Introduction
Obesity is a prevalent health hazard closely associated with a
number of pathological disorders, including type 2 diabetes,
cardiovascular disease, hypertension, cancer, and gallbladder
disease. Adipocytes play a central role in energy balance, both
as reservoirs of fuel and as endocrine cells, secreting factors
(adipokines) that regulate whole body energy metabolism and
glucose homeostasis [1]. Adipogenesis is a complex process that is
highly regulated by positive and negative stimuli, including a
variety of hormones and nutritional signals [2,3,4,5]. Adipocyte
differentiation is commonly studied in immortalized cell lines such
as 3T3-L1 preadipocytes [2,4,6] and the pluripotent bone
marrow-derived mesenchymal cell line ST2 [7], both of which
can be differentiated into mature adipocytes by standard hormone
cocktails. During adipogenesis, fibroblast-like preadipocytes dif-
ferentiate into lipid-laden and insulin-responsive adipocytes. This
process occurs in several stages (growth arrest, mitotic clonal
expansion and terminal differentiation) and is driven by the
coordinated effects of a number of transcription factors and
signaling molecules, including peroxisome proliferator-activated
receptor gamma (PPARc), the CCAAT/enhancer-binding pro-
teins (C/EBPs) [4,8], Kruppel-like factors (KLFs) [9,10], Wingless
proteins (Wnt) [11,12], GATA2 [13,14] and cell cycle proteins
[15,16,17].
Transcription factors function in part by recruiting coregulators that
epigenetically remodel chromatin and/or bridge the complexes in
which they reside to the basal transcriptional machinery. Some
coregulators important in adipogenesis have essential enzymatic
activities, such as the SW1/SNF complex that controls ATP-
dependent chromatin remodeling [18,19], and the histone acetyltrans-
ferase proteins CBP and p300 [20,21]. Others, such as the p160 family
of coactivators, SRC-1, TIF2/SRC-2 and AIB1/SRC-3, function as
scaffolds, although they also have some histone acetyltransferase
activity [22,23,24]. Conversely, corepressors such as nuclear receptor
corepressor (NCoR) and silencing mediator of retinoid and thyroid
hormone receptors (SMRT) recruit histone deacetylases to target
promoters, and therefore are anti-adipogenic [25].
The steroid receptor RNA activator (SRA) is a unique
coregulator that functions as a non-coding RNA [26], although
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14199Figure 1. SRA binds to PPARc in vitro and enhances its transcriptional activity. A, Schematic presentation of full length PPARc and its
truncation mutants used for in vitro RNA binding studies. Purified full-length GST, GST-PPARc, and truncation proteins GST-PPARcLBD and GST-
PPARcDLBD bound to glutathione agarose beads were incubated with a
32P-labeled SRA (RNA) probe. After washing, the radioactivity associated
with the beads was determined by liquid scintillation counting. B, JEG cells were transfected with 1 ng of PPARc and RXRa 10 ng of the internal
control vector pRL-TK-Renilla, 200 ng PPRE-luc, and increasing doses of SRA as indicated. One day post-transfection, the cells were treated with or
without ciglitizone, and cells were harvested for firefly and Renilla luciferase assays after an additional day. C. Similar transfection to B, but cells were
treated with the RXR ligand 9-cis-RA. D, Similar transfection to B, but without cotransfection of RXR. E, JEG cells were transfected with 50 ng of p42C/
EBPa 1 ng of the internal control vector pRL-CMV570-Renilla, 150 ng pObluc-760-luc, and increasing doses of SRA as indicated. 48 hr post-
transfection, cells were harvested for firefly and Renilla luciferase assays. For B, C, D and E, the y axis represents arbitrary firefly luciferase units
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an SRA protein (SRAP) that also has coactivator activity [27,28].
SRA was initially shown to enhance gene expression through a
ribonucleoprotein complex with steroid receptors and SRC-1 [26].
SRA also functions as an RNA coactivator for thyroid hormone
receptors (TRs) [29,30], retinoic acid receptors (RARs) [30] and
the muscle cell differentiation factor MyoD [31]. In addition, SRA
may act as an RNA scaffold for corepressor complexes [32,33]. A
potential role for SRA in adipogenesis has yet to be explored.
In this study, we report that SRA binds to PPARc in vitro and in
3T3-L1 adipocytes, and enhances PPARc transcriptional activity.
SRA promotes adipocyte differentiation; up-regulates the expres-
sion of PPARc, C/EBPa and other adipocyte genes; and increases
glucose uptake and phosphorylation of Akt and FOXO1 in
response to insulin. To uncover mechanism(s) by which SRA
regulates adipocyte function, we identified SRA responsive genes
by gene expression profiling analysis of SRA overexpressing ST2
cells and SRA knockdown 3T3-L1 cells that had been differen-
tiated into mature adipocytes. The data show that SRA regulates
gene expression networks in various cellular processes, including
the cell cycle and insulin related signal transduction pathways.
Indeed, SRA promotes S-phase entry during mitotic clonal
expansion and inhibits phosphorylation of c-Jun NH2-terminal
kinase (JNK) in response to tumor necrosis factor-a (TNFa)
signaling.
Results
The non-coding steroid receptor RNA activator (SRA) is a
transcriptional coactivator of PPARc
SRA was initially identified as a coactivator of steroid
receptors [26] and has subsequently been shown to coactivate
several nonsteroid nuclear hormone receptors such as thyroid
hormone receptors [29], RARs [30] and SF-1 [34]. SRA is
enriched in liver, skeletal muscle [26] and adipose tissue
(described below), which are important organs for controlling
whole body energy balance, glucose homeostasis and insulin
sensitivity. Therefore, we tested whether SRA binds to and
coactivates PPARc, a critical transcriptional regulator of these
processes.
As shown in Figure 1A, SRA binds to full length PPARc in vitro.
To identify the protein region responsible for RNA binding, we
tested PPARc deletion mutants. This revealed that the PPARc
ligand binding domain (LBD) does not bind to SRA, and the N-
terminal half of PPARc accounts for the full SRA-binding capacity
(DLBD). This result is consistent with the SRA binding properties
of thyroid hormone receptors and SF-1 [29,34,35]. The finding
that SRA binds to PPARc in vitro prompted us to test for its
functional relevance to PPARc target gene transcription. To this
end, a reporter plasmid containing three copies of the acyl-CoA
oxidase PPAR response element linked to the luciferase gene
(PPRE-luc) was co-transfected with PPARc, RXRa, pRL-TK
Renilla luciferase as an internal control, and increasing quantities of
SRA in JEG-3 cells. PPARc ligand (ciglitizone)-dependent
transactivation of PPRE-luc was increased by SRA in a dose-
dependent manner (Figure 1B). However, RXRa ligand (9-cis-
RA)-dependent transactivation of the same reporter construct was
not affected by SRA (Figure 1C). SRA also coactivated PPARc/
ciglitazone-dependent luciferase expression in the absence of
cotransfected RXR (Figure 1D). In contrast, SRA did not
coactivate C/EBPa induction of a leptin promoter-luciferase
vector (Figure 1E).
SRA expression is induced during adipocyte
differentiation and SRA is highly expressed in white
adipose tissue
SRA expression was induced ,2 fold when 3T3-L1 preadipo-
cytes differentiated into mature adipocytes (Figure 2A). In
addition, we found SRA to be more highly expressed in mouse
white adipose tissue (WAT) than liver, an organ previously shown
to express SRA at high levels [26]. These data suggest that SRA
may play an important role in adipocyte biology.
SRA overexpression promotes differentiation of
adipocyte precursor ST2 cells
To probe whether SRA can modulate adipogenesis, we used
marrow-derived mesenchymal ST2 cells as an in vitro model. SRA
RNAwasoverexpressed,140 fold throughretroviralinfectionwith
pMSCV-SRA (data not shown). Confluent, growth-arrested ST2
adipocyte precursors were treated with fetal bovine serum (FBS) or
were induced to differentiate with a hormone cocktail containing 3-
isobutyl-1-methylxanthine, dexamethasone, and insulin, denoted
MDI, or troglitazone was added to the hormone cocktail (MDIT).
At day 4 of differentiation, Oil Red O staining was used to visualize
lipid droplets, which characterize mature adipocytes. As shown in
Figures 2B and S1A, compared to control ST2 cells that were
infected with pMSCV empty vector, SRA overexpression promoted
adipogenesis slightly when no differentiation cocktail was used
(FBS), and more markedly with the differentiation cocktail MDI.
MDIT is a more powerful differentiation cocktail, and hence little
additional triacylglycerol accumulation was seen with SRA
overexpression in MDIT-treated ST2 cells (Figures 2B and S1A).
We used RT-qPCR and immunoblotting to confirm the positive
effect of SRA on expression of adipocyte marker genes in ST2 cells
differentiated with MDI. As shown in Figure 2C, after 4 days of
differentiation, SRA overexpression significantly enhanced the
mRNA expression of adipocyte master regulators PPARc and C/
EBPa, as well as the PPARc target gene fatty acid binding protein 4
(FABP4/aP2) and the adipocyte specific gene adiponectin.
Consistent with these effects on mRNA expression, SRA also
increased the protein expression of adipocyte markers (Figure 2D).
Time course data indicate that from day 2 of differentiation, SRA
increased protein expression ,2 fold over control cells for PPARc1,
PPARc2, and p42 and p30 C/EBPa, and more than 3 fold for
FABP4/aP2 (Figure 2D). These results suggest that SRA is a pro-
adipogenic factor.
SRA knockdown inhibits the differentiation of 3T3-L1
preadipocytes
Since the endogenous SRA level in 3T3-L1 cells is 2-3 fold
higher than in ST2 cells (data not shown), we used 3T3-L1 cells to
evaluate the effects of SRA depletion on adipogenesis. First, we
tested whether endogenous SRA is associated with PPARc in
adipocytes. RNA-protein co-immunoprecipitation was performed
from fully differentiated 3T3-L1 adipocytes using either of two
different PPARc antibodies or normal IgG as a negative control.
normalized to Renilla luciferase values. Experiments were performed with triplicate samples and were repeated three times. Error bars indicate
standard deviations. The results of statistical analyses by analysis of variance (ANOVA) followed by Scheffe’s test, comparing bar 2 without SRA
transfection under ciglitizone induction with bars with SRA transfections and ciglitizone inductions (* p,0.05 and ** p,0.01).
doi:10.1371/journal.pone.0014199.g001
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was performed to quantify the immunoprecipitated SRA. The
results indicate that endogenous SRA RNA coimmunoprecipitates
with PPARc (Figure 2E), demonstrating a physical interaction
between these molecules within adipocytes.
Next, endogenous SRA was knocked down in subconfluent
3T3-L1 preadipocytes with retroviral expression of short hairpin
RNAs (shRNA) against SRA. Two shRNAs (shSRA-1, -2) with
different targeting sequences in mouse SRA1 were designed and
transduced into 3T3-L1 preadipocytres. Preadipocytes stably
infected with retroviral shSRAs or shControl were then induced
to differentiate with MDI, and samples from different time points
were collected for RNA or protein analysis. Both shSRAs
efficiently knocked down endogenous SRA to ,20% of control
at day 0 and throughout differentiation (Figure 2F). We then
investigated the effects of SRA knockdown on adipocyte
differentiation. As shown in Figures 2G and S1B, on day 8 of
differentiation with MDI induction, lipid accumulation (Oil Red
O staining) was dramatically decreased in adipocytes harboring
shSRA-1 or -2. In contrast, little if any decreased triacylglycerol
accumulation was seen with SRA knockdown in MDIT-treated
3T3-L1 cells (Figures 2G and S1B), presumably because this
strong differentiation cocktail largely relieves the dependence on
SRA for adipocyte differentiation.
The inhibitory effect of SRA knockdown on MDI-induced
adipogenesis was studied further at the RNA and protein levels.
PPARc and C/EBPa mRNAs were significantly decreased in day
8 adipocytes with endogenous SRA knockdown by shSRA-1 or -2,
compared to shControl (Figures 2H and 2I). Small but significant
decreases in PPARc mRNA were found as early as day 2 of
adipogenesis, and C/EBPa mRNA levels were inhibited even on
day 0. As expected from decreased adipogenic transcription factor
expression, upregulation of the adipocyte markers FABP4/aP2
and adiponectin was significantly inhibited by both shSRA-1 and -
2 (Figure 2J and 2K). Immunoblotting analysis confirmed these
effects of SRA knockdown at the protein level (Figure 2L). In SRA
knockdown cells, inhibition of PPARc protein expression was
observed beginning at day 4 of differentiation compared to
shControl cells. The inhibitory effect of SRA knockdown on C/
EBPa protein expression was most apparent at days 2 and 8.
FABP4/aP2 protein expression was inhibited from day 2 onward.
Furthermore, protein expression of adiponectin, an anti-inflam-
matory adipokine that was detected only on day 8, also was
inhibited by SRA knockdown. In addition to FABP4/aP2
(Figure 2J), the mRNA expression of various other PPARc target
genes also was decreased by SRA knockdown (Figure 2M).
Genome-wide identification of SRA responsive genes
To gain further insight into the functions of SRA in adipocyte
biology, which may extend beyond coactivation of PPARc,w e
performed an Affymetrix GeneChip microarray analysis to
identify SRA responsive genes in SRA overexpressing ST2
adipocytes and SRA knockdown 3T3-L1 adipocytes, versus their
respective control cells. These experiments utilized cells that had
been maximally differentiated with MDIT (4 days for ST2 and 8
for 3T3-L1), since under those conditions SRA overexpression or
knockdown has relatively little effect on adipogenesis (Figures 2B,
2G and S1). Thus, this experimental design is more likely to reveal
effects of SRA in mature adipocytes beyond its ability to enhance
adipogenesis via PPARc coactivation. As shown in Figure 3, we
first identified genes whose expression was significantly changed in
ST2 adipocytes overexpressing SRA compared to controls. A total
of 1687 genes/expressed-sequence tags (ESTs) were significantly
altered (p,0.05). Among these, 421 were up-regulated and 1266
were down-regulated by SRA overexpression. For 3T3-L1
adipocytes, the expression of 340 genes/ESTs was altered by
endogenous SRA knockdown (145 up, 195 down). Sixty genes/
ESTs (intersection genes) were commonly regulated (and in
opposite directions) by SRA overexpression in ST2 adipocytes
and endogenous SRA knockdown in 3T3-L1 adipocytes. Heat
maps representing gene expression levels are shown in Figure 3,
and the complete data set has been deposited in the Gene
Expression Omnibus (accession number GSE21594).
The 1687 genes regulated by SRA overexpression, the 340
genes regulated by SRA knockdown, and the 60 intersection genes
were each analyzed for over-representation of Gene Ontology
(GO) biological processes (BP) and molecular functions (MF). The
most overrepresented GO terms are listed in Tables 1, 2, 3, 4, 5, 6.
Full listings of overrepresented GO terms are provided in Tables
S1, S2, S3, S4, and listings of the significantly changed genes
associated with these GO terms are provided in Data Sets S1, S2,
S3. Selected GO term findings are presented and expanded upon
below.
SRA promotes insulin sensitivity and insulin-stimulated
glucose uptake in adipocytes, and increases
phosphorylation of Akt and FOXO1 in response to insulin
The GO term Insulin Receptor Signaling Pathway was
overrepresented in the gene list from SRA overexpressing ST2
cells (Table S1). Elevated SRA repressed the expression of several
genes within this GO term that function as negative regulators of
insulin sensitivity (Table 7), including suppressor of cytokine
Figure 2. SRA is highly expressed in adipocytes and is pro-adipogenic. A, RT-qPCR was performed to measure SRA RNA levels in 3T3-L1
preadipocytes, mature 3T3-L1 adipocytes, mouse white adipose tissue (WAT) and mouse liver. RNA expression was normalized to cyclophilin mRNA,
and expression is given relative to SRA in 3T3-L1 preadipocytes set at 1. B, Control (pMSCV empty vector; Cont.) or SRA overexpressing ST2 cells were
grown to confluence and treated with FBS, MDI or MDIT to induce adipocyte differentiation. On day 4 of differentiation, cells were stained with Oil
Red O to identify triglyceride droplets. C and D, Control and SRA overexpressing ST2 cells were induced by MDI to differentiate into adipocytes. The
mRNA (C) or protein levels (D) of adipocyte marker genes were determined by RT-qPCR or immunoblotting, respectively. E, 3T3-L1 cells were
differentiated into adipocytes with MDIT. Cell lysates from day 8 of differentiation were immunoprecipitated using two PPARc antibodies as indicated
or normal IgG as a negative control. The immunoprecipitates were subjected to RT-qPCR with primers for mouse SRA or cyclophilin RNA as a non-
specific control. The ratio of SRA/cyclophilin in the immunoprecipitates with normal IgG was set at 1. F-L, 3T3-L1 preadipocytes were infected with
retroviruses expressing either a control short hairpin RNA (shControl) or one of two shRNAs directed against mouse SRA target sequences (shSRA-1 or
-2). Preadipocytes were induced to differentiate with MDI, except MDIT was used for G, lower panel. F, Time course of SRA RNA expression normalized
to cyclophilin. G, At day 8 of differentiation, cells were stained with Oil Red O to assess lipid accumulation. H–K, Time course of mRNA expression for
adipocyte marker genes PPARc (H), C/EBPa (I), FABP4/aP2 (J), and adiponectin (K) by RT-qPCR. Data were normalized to cyclophilin and expression of
each gene at day 0 was set to 1. L, Time course of adipocyte marker protein expression by immunoblotting. M, shControl or shSRA-2 3T3-L1
preadipocytes were differentiated with MDI. At day 8 of differentiation, RT-qPCR was used to measure relative mRNA expression levels for PPARc
target genes, normalized to cyclophilin. The average normalized expression of each target mRNA in control cells is set at 1. Data are given as the
mean 6 S.D. Statistical significance was evaluated with Student’s t test: * p,0.05, ** p,0.01 and *** p,0.001. These results are representative of
three independent experiments.
doi:10.1371/journal.pone.0014199.g002
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forkhead box C2 (Foxc2) [36,37,38,39]. In contrast, SRA
overexpression increased the expression of sorbin and SH3
domain containing 1 (Sorbs1), which encodes Cbl-associated
protein (CAP), part of a phosphatidylinositol 3-kinase-independent
pathway for insulin-stimulated translocation of the glucose
transporter GLUT4 [40]. These results were confirmed by RT-
qPCR (Figure 4). Given these data, the ability of SRA to promote
insulin-stimulated glucose uptake was examined in differentiated
adipocytes. We wished to assess whether the postulated ability of
SRA to enhance this insulin action is simply a marker of better
differentiation, or whether SRA might have a specific effect on
insulin-stimulated glucose uptake beyond its general ability to
enhance differentiation. Therefore, we differentiated preadipo-
cytes with MDIT rather than MDI, since, as noted previously,
under MDIT conditions the expression level of SRA has relatively
little effect on adipocyte differentiation (Figures 2B, 2G and S1).
Indeed, our data demonstrate that fully differentiated ST2
adipocytes overexpressing SRA have increased insulin-stimulated
glucose uptake (Figure 5A). Consistent with these data, SRA
overexpression also was associated with increased insulin-stimu-
lated phosphorylation of Akt at both Ser-473 and Thr-308, as well
as increased phosphorylation of FOXO1, a downstream target of
Akt signaling (Figure 5B). Conversely, fully differentiated 3T3-L1
adipocytes with knockdown of endogenous SRA had decreased
insulin-stimulated glucose uptake (Figure 5C) and decreased
phosphorylation of Akt and FOXO1 (Figure 5D). These data
support the hypothesis that SRA not only regulates adipogenesis,
but also enhances insulin signaling and glucose uptake.
Cell cycle genes are reciprocally regulated by SRA
overexpression in ST2 adipocytes and SRA knockdown in
3T3-L1 adipocytes
Two of the top 5 intersection gene GO-BP terms are CellDivision
and M Phase (Table 5). Within these GO terms, the cell cycle and
DNAreplication-associated genesMcm5,Cdc20,Tacc1,Mki67and
Ncapd2weresignificantlydown-regulatedbySRAoverexpressionin
ST2 cells and up-regulated by endogenous SRA knockdown in 3T3-
L1 cells (Figure 3 and Data Set S3). RT-qPCR was used to confirm
these changes for Mcm5, Cdc20, Ncapd2 and Mki67 (Figure 6A–
6D). Similarly, 4 of the 6 most enriched GO-BP terms in SRA
overexpressing cells were related to the cell cycle, cell division and
mitosis (Table 1). The genes associated with the GO terms Mitotic
Cell Cycle and DNA Replication Initiation that are most
significantly regulated by SRA overexpression are listed in Table 8.
Among these, several cyclin genes (Ccnb2, Ccnb1-rs1 and Ccna2),
cell cycle-related genes (Ereg, Birc5, Ube2c, Bub1, Cep55) and cell
division genes(Cdca5 and Cdc20) were down-regulated morethan 2
fold by SRA overexpression. The repression of Ccnb1-rs1, Ccna2,
Ube2c and Bub1 by SRA overexpression was confirmed by RT-
qPCR, which also demonstrated that these genes are induced by
SRA knockdown in 3T3-L1 cells (Figure 6E–6H). Overall, these
data suggest that SRA plays a modulatory role in promoting
withdrawal from the cellcycle during the final stagesofadipogenesis.
SRA regulates S-phase entry during mitotic clonal
expansion
Reentry into the cell cycle is one of the key events in early
adipogenesis. Post-confluent preadipocytes become growth arrested
at the G0-to-G1 cell cycle transition due to contact inhibition [41].
Upon hormonal induction, growth-arrested 3T3-L1 preadipocytes
synchronously re-enter the cell cycle and undergo several rounds of
cell division, known as mitotic clonal expansion (MCE). MCE is an
essential step in adipocyte maturation [42] in some preadipocyte
models. Given that our microarray analysis revealed SRA-
dependent changes in the expression of cell cycle genes in mature
adipocytes, we investigated whether SRA regulates cell cycle
progression during MCE. Growth arrested SRA overexpressing
and control ST2 preadipocytes were induced to differentiate with
MDIT. FACS analysis of propidium iodide-stained cells was
performed every 2 h to elucidate the cell cycle profile during
MCE. Similar studies were performed in endogenous SRA
knockdown (shSRA) and shControl 3T3-L1 preadipocytes. As
shown in Figure 7A (left), SRA overexpression in ST2 preadipocytes
promotes re-entry to the cell cycle during MCE. SRA ST2 cells had
an S-phase peak 14 h after hormone induction (with a concomitant
decrease in G1 cells), followed 4 h later by a G2/M phase peak.
These changes were not observed in control ST2 cells. Conversely,
stable knockdown of endogenous SRA in 3T3-L1 preadipocytes
inhibited S-phase entry and the transition to G2/M phase during
MCE post-MDIT (Figure 7A, right). SRA overexpression also
increased BrdU incorporationin the 10–14 h post-MDITinduction
by about 2-fold over control ST2 cells (Figure S2), further
confirming the ability of SRA to promote S-phase entry in ST2
preadipocytes. In addition, SRA overexpression increased the cell
number by ,30% 24 h post-MDIT (Figure 7B).
Cell cycle-related genes are regulated by SRA during MCE
and adipocyte maturation
Cell cycle progression from G1 to S phase is dependent on the
expression of cyclins and cyclin-dependent kinase (CDKs). In
addition, cyclin-dependent kinase inhibitors (CKIs) such as the
CIP/KIP protein family can bind to cyclin/CDK complexes to
inhibit the G1-S phase transition [43]. Cyclin-dependent kinase
Figure 3. Microarray analysis of mRNA expression of SRA responsive genes. Total RNA was isolated from fully differentiated (MDIT day 4)
SRA overexpressing and control ST2 adipocytes, or fully differentiated (MDIT day 8) shSRA knockdown or shControl 3T3-L1 adipocytes. Gene
expression analysis was performed using Affymetrix mouse genome 430 2.0 arrays. The Venn diagram shows the number of genes with significant
expression changes in SRA overexpressing versus control ST2 adipocytes (left, yellow), genes that changed in endogenous SRA knockdown versus
control 3T3-L1 adipocytes (right, blue), and the intersection genes. Heat maps are shown for Log2 expression changes of SRA responsive genes
corresponding to the above comparisons. Increased or decreased mRNA expression is represented by red or green color, respectively.
doi:10.1371/journal.pone.0014199.g003
Table 1. Top six GO terms in biological processes (BP)
overrepresented amongst genes with altered expression in
SRA overexpressing versus empty vector control ST2
adipocytes.
GO BP ID Pvalue ExpCount Count Size Term
GO:0000278 ,0.001 26 58 153 mitotic cell cycle
GO:0007067 ,0.001 20 46 115 mitosis
GO:0006955 ,0.001 32 64 188 immune response
GO:0007155 ,0.001 47 85 278 cell adhesion
GO:0051301 ,0.001 29 57 169 cell division
GO:0000279 ,0.001 25 51 146 M phase
doi:10.1371/journal.pone.0014199.t001
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adipocyte differentiation during both the progression of MCE and
in the final exit from the cell cycle during terminal differentiation
[44,45]. In addition, loss of CKIs in vivo produces adipocyte
hyperplasia and obesity [46]. Given that our data demonstrate a
role for SRA to promote entry into S-phase during MCE, we
tested whether SRA regulates the expression of CKIs during
preadipocyte differentiation. We found that SRA overexpression
inhibits p21Cip1 expression from day 0 (before MDIT induction)
through the early time points of MCE (up to 10 h post-MDIT),
but subsequently up-regulates p21Cip1 after MCE (24 h) until
terminal differentiation on day 4 (Figure 7C). The effect of SRA
overexpression on p27Kip1 was qualitatively similar but the
magnitude of change was far less (Figure 7C). Conversely,
knockdown of endogenous SRA in 3T3-L1 preadipocytes up-
regulated p21Cip1 and p27Kip1 protein expression during MCE
(30 min, 6 h, 18 h), but down-regulated their expression after
MCE (day 2) until terminal differentiation on day 6 (Figure 7D,
upper panel). Progress of the mammalian cell cycle is also
regulated by phosphorylation of other key proteins. Cdk1/Cdc2 is
the catalytic subunit for maturation promoting factor (MPF),
which includes the regulatory subunit of cyclin B. After binding to
cyclin B, Cdc2 is phosphorylated on Tyr-15, yielding an inactive
form of the pre-MPF complex during G2 phase and inhibiting cell
entry into M phase [47,48]. Knockdown of endogenous SRA in
3T3-L1 preadipocytes up-regulated the phosphorylation of Tyr-15
on Cdc2 during MCE (Figure 7D; lower panel). Thus, the effects
of SRA on the expression of p21Cip1 and p27Kip1, and the
phosphorylation of Cdk1/Cdc2, are consistent with the ability of
SRA to promote MCE of preadipocytes and the terminal
differentiation of 3T3-L1 adipocytes.
SRA regulates inflammatory response genes
Adipocytes are now recognized to form a multifunctional
organ not only for lipid storage but also for secreting numerous
adipokines and cytokines that play roles in inflammation and
insulin sensitivity [1]. Therefore it is interesting that the most
enriched GO term associated with the intersection genes is
Inflammatory Response, and the fourth such GO term is
Regulation of Cytokine Biosynthetic Process (Table 5). As shown
in Data Set S3, four intersection genes associated with
inflammation were negatively regulated by SRA. These include
zinc finger protein 36 (zfp36), toll-like receptor 4 (Tlr4),
haptoglobin (Hp) and N-deacetylase/N-sulfotransferase (heparan
glucosaminyl) 1 (Ndst1). Perhaps most interesting among these is
Tlr4, which can be activated by nutritional fatty acids to
promote insulin resistance [49]. The microarray data also
identified a number of inflammatory response genes negatively
regulated by SRA overexpression in ST2 cells that were not
significantly changed in the SRA knockdown cells (Table 9). The
most strongly regulated gene in this group is Ccl2 (also known as
MCP-1), which is a macrophage-attracting chemokine highly
expressed in adipose tissue. Overexpression of MCP-1 has been
shown to contribute to macrophage infiltration of adipose tissue
and insulin resistance, while ablation of either MCP-1 or its
receptor has the opposite effect [50,51,52]. The inhibitory effect
of SRA on expression of Tlr4, Ccl2 and several additional
inflammatory genes was confirmed by RT-qPCR (Figure S3).
Overall, these changes suggest that SRA may have anti-
inflammatory functions within adipose tissue, which might
contribute to the ability of SRA to enhance insulin sensitivity
(Figure 5).
Table 2. Top six GO terms in molecular function (MF) overrepresented amongst genes with altered expression in SRA
overexpressing versus empty vector control ST2 adipocytes.
GO MF ID Pvalue ExpCount Count Size Term
GO:0005509 ,0.001 65 102 393 calcium ion binding
GO:0004872 ,0.001 56 85 339 receptor activity
GO:0003779 ,0.001 23 41 138 actin binding
GO:0060089 ,0.001 115 151 691 molecular transducer activity
GO:0030020 ,0.001 3 10 18 extracellular matrix structural constituent conferring
tensile strength
GO:0003924 0.001 16 29 95 GTPase activity
doi:10.1371/journal.pone.0014199.t002
Table 3. Top six GO terms in biological processes (BP) overrepresented amongst genes with altered expression in endogenous
SRA knockdown versus control 3T3-L1 adipocytes.
GO BP ID Pvalue ExpCount Count Size Term
GO:0007155 ,0.001 8 21 278 cell adhesion
GO:0006817 ,0.001 1 6 28 phosphate transport
GO:0030199 ,0.001 0 4 12 collagen fibril organization
GO:0007169 ,0.001 3 10 92 transmembrane receptor protein tyrosine kinase
signaling pathway
GO:0048675 ,0.001 0 4 13 axon extension
GO:0007275 ,0.001 28 45 978 multicellular organismal development
doi:10.1371/journal.pone.0014199.t003
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functionally related gene sets amongst SRA-responsive
genes, including gene sets related to TNFa signaling
GSEA was designed to detect modest but coordinated changes
in the expression of groups of functionally related genes [53].
Using GSEA, we identified .100 gene sets that were down-
regulated by SRA overexpression in fully differentiated ST2
adipocytes versus control cells (Table S5). Most of these gene sets
relate to processes already identified through the GO term
analysis: cell cycle, adipocyte differentiation, and cell proliferation.
Perhaps most interesting, however, the ninth most enriched gene
set to be repressed by SRA overexpression in ST2 cells was
NEMETH_TNF_UP (Q,E-06); i.e., SRA repressed genes that
are induced by TNFain this gene set (Figure 8A and Table S5). In
contrast, the most significant gene set that was up-regulated by
SRA overexpression is TNFALPHA_ADIP_DN; i.e., SRA
induced genes that are repressed by TNFa in this gene set
(Figure 8B and Table S6). The gene sets enriched by SRA
knockdown in 3T3-L1 adipocytes (Tables S7, S8) also overlapped
with processes uncovered through the GO term analysis.
Interestingly, however, SRA knockdown resulted in up-regulation
of the gene set TNFALPHA_30min_UP. These data suggest that
SRA may negatively regulate signaling through TNFa,a
possibility that we explored subsequently.
SRA inhibits TNFa phosphorylation of JNK
Proinflammatory cytokines including TNFa are produced in
adipose tissue and are secreted from cultured adipocytes in vitro.
TNFa induces expression of SOCS proteins [54] and activates
(phosphorylates) JNK [55]. Both SOCS and JNK are negative
regulators of insulin signaling and can cause insulin resistance
[56,57]. Given that the GSEA of our microarray data suggests that
SRA may negatively regulate TNFa signaling, we examined the
ability of SRA to influence TNFa-induced JNK phosphorylation.
As expected, TNFa stimulated JNK phosphorylation in control
ST2 adipocytes, but this phosphorylation was impaired in ST2
cells overexpressing SRA (Figure 8C). Conversely, knockdown of
SRA in 3T3-L1 adipocytes enhanced TNFa-induced JNK
phosphorylation (Figure 8D). These results, combined with the
previous data, indicate that SRA has anti-inflammatory effects in
adipocytes.
SRA knockdown in mature adipocytes confirms its ability
to enhance insulin sensitivity and inhibit TNFa signaling
In the above studies, we either stably overexpressed SRA in ST2
preadipocytes or knocked down SRA in 3T3-L1 preadipocytes,
and then investigated the properties of cells following differenti-
ation. The data indicate that preadipocytes are dependent on SRA
for differentiation in response to MDI, but that SRA has very little
effect on differentiation by the stronger hormone cocktail MDIT.
Since SRA enhances insulin action and represses TNFa signaling
in MDIT-differentiated cells (Figures 5, 8), we concluded that
these effects likely reflect actions of SRA within the mature
adipocyte, rather than effects on adipocyte differentiation.
However, to further evaluate this conclusion, we employed a
lentiviral system (pLentiLox3.7-shSRA) to stably knock down SRA
in already-differentiated 3T3-L1 adipocytes, and then determined
the effects of SRA knockdown on insulin and TNFasignaling.
More than 80% of adipocytes were infected by the lentivirus based
upon the expression of eGFP encoded by the viral construct (data
not shown). As shown in Figure 9A, endogenous SRA was
efficiently knocked down in mature 3T3-L1 adipocytes by
lentiviral shSRA expression (pLentiLox3.7-shSRA) versus control
Table 4. Top six GO terms in molecular function (MF) overrepresented amongst genes with altered expression in endogenous SRA
knockdown versus control 3T3-L1 adipocytes.
GO MF ID Pvalue ExpCount Count Size Term
GO:0004872 ,0.001 17 34 588 receptor activity
GO:0048503 ,0.001 1 8 51 GPI anchor binding
GO:0019199 ,0.001 1 6 36 transmembrane receptor protein kinase activity
GO:0060089 0.001 20 35 691 molecular transducer activity
GO:0005543 0.001 3 10 101 phospholipid binding
GO:0030020 0.001 1 4 18 extracellular matrix structural constituent conferring
tensile strength
doi:10.1371/journal.pone.0014199.t004
Table 5. GO terms in biological processes (BP) overrepresented amongst the intersection genes.
GO BP ID Pvalue ExpCount Count Size Term
GO:0006954 0.002 1 4 90 inflammatory response
GO:0000271 0.002 0 2 13 polysaccharide biosynthetic process
GO:0051301 0.002 1 5 169 cell division
GO:0042035 0.008 0 2 24 regulation of cytokine biosynthetic process
GO:0000279 0.009 1 4 146 M phase
GO:0019882 0.01 0 2 27 antigen processing and presentation
GO:0009607 0.01 0 3 80 response to biotic stimulus
doi:10.1371/journal.pone.0014199.t005
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mature adipocytes had no effect on the accumulation of neutral
lipid, as determined by Oil Red O staining (Figure 9B, left panel),
nor on the expression of the adipocyte marker genes PPARc,C /
EBPa, FABP4 or adiponectin (Figure 9B, right panel). Impor-
tantly, however, lentiviral SRA knockdown inhibited insulin-
stimulated glucose uptake (Figure 9C) to a similar extent as
retroviral knockdown in preadipocytes followed by differentiation
(Figure 5C). Furthermore, knockdown of SRA in differentiated
3T3-L1 cells inhibited the phosphorylation of Akt and FOXO1 in
response to insulin (Figure 9D upper panel), and up regulated
TNFa-stimulated JNK phosphorylation (Figure 9D, lower panel).
Again, these effects are similar to those observed with retroviral
knockdown in preadipocytes, followed by differentiation
(Figure 5D). These data suggest SRA may play a direct role in
improving insulin sensitivity through up-regulating the insulin
signaling pathway and down-regulating TNFa signaling.
Discussion
The non-coding RNA SRA functions as an RNA coactivator for
several nuclear hormone receptors including steroid receptors
[26], thyroid hormone receptors [29,33], retinoic acid receptors
[30], vitamin D receptors [33], and steroidogenic factor-1 [34],
but it has not been studied in association with PPARc. SRA is
highly expressed in energy-demanding and mitochondria-rich
tissues such as skeletal muscle, liver and heart [26]. Here, we show
that SRA is expressed at a higher level in mouse WAT than liver.
Given that PPARc is a key transcriptional regulator of adipocyte
biology [1,8,58], we hypothesized that SRA binds to PPARc and
has functional importance in adipogenesis. Indeed, we found that
SRA binds to PPARc in vitro, and that the ligand-binding domain
is not required for this interaction. This result is consistent with the
binding of SRA to other nuclear hormone receptors. SRA also
binds to PPARc in mature adipocytes, as assessed by RNA-protein
co-immunoprecipitation (Figure 2E). Although SRA enhanced
PPARc transactivation in a ligand-dependent manner, it did not
increase RXR or C/EBPa mediated transcription, indicating that
SRA has some specificity as a coactivator. Our results, together
with a recent report that SRA increased PPARd-dependent
reporter gene activity [33], suggest that SRA might be a common
coactivator for PPAR family proteins.
The ability of SRA to coactivate PPARc explains, at least in
part, our observations that overexpression of SRA promotes MDI-
induced adipogenesis in ST2 cells (Figure 2A–2D), and depletion
of SRA impairs MDI-induced adipogenesis in 3T3-L1 cells
(Figure 2F–2M). However, SRA has very little effect on
adipogenesis in response to the more powerful differentiation
cocktail MDIT, presumably because troglitazone allows for strong
PPARc signaling even when SRA levels are low. Although this
may seem paradoxical given the observation that SRA functions as
a PPARc coactivator in the presence of the related ligand
ciglitazone (Figure 1), those studies were performed in transiently
transfected JEG-3 choriocarcinoma cells, which lack the adipocyte
milieu.
Gene expression profiling was performed on SRA-overexpress-
ing ST2 adipocytes and SRA knockdown 3T3-L1 adipocytes,
versus their respective control adipocytes. The cells had been
maximally differentiated with MDIT since, under those condi-
tions, SRA has relatively little effect on adipogenesis. Thus, the
microarray analysis should allow for the identification of genes and
pathways regulated by SRA in mature adipocytes that may be
independent of its action as a PPARc coactivator to promote
adipogenesis. These studies resulted in the identification of 1687
genes with altered expression between SRA overexpresing and
control ST2 adipocytes, 340 genes that differed in expression
between SRA knockdown and control 3T3-L1 adipocytes, and
sixty intersection genes that were oppositely regulated by SRA
overexpression and knockdown. Since ST2 cells derive from
mouse bone marrow and can differentiate along several different
lineages [7,59,60,61], while 3T3-L1 cells are mouse fibroblast
preadipocytes [6], it is perhaps not surprising that only a modest
overlap is found between the SRA-dependent gene expression
changes when these two cell lines are differentiated into
adipocytes. We focused our attention primarily on these
intersection genes, since they are more likely to be of significance
for adipocyte biology. Although many of the changes are
Table 6. GO terms in molecular function (MF)
overrepresented amongst the intersection genes.
GO MF ID Pvalue ExpCount Count Size Term
GO:0005520 0.003 0 2 16 insulin-like growth
factor binding
doi:10.1371/journal.pone.0014199.t006
Table 7. Genes associated with the GO term insulin receptor signaling pathway that have significantly altered expression in SRA
overexpressing ST2 cells.
Probe set Symbol Gene name p-value Fold change*
Insulin receptor signaling pathway
1455899_x_at Socs3 suppressor of cytokine signaling 3 ,0.001 21.64
1450945_at Prkca protein kinase C, alpha ,0.001 20.91
1455706_at Stxbp4 syntaxin binding protein 4 ,0.001 20.82
1416693_at Foxc2 forkhead box C2 ,0.001 20.55
1450446_a_at Socs1 suppressor of cytokine signaling 1 0.001 20.43
1425098_at Zfp106 zinc finger protein 106 0.002 0.5
1444472_at Snf1lk2 SNF1-like kinase 2 0.001 0.6
1443983_at Sorbs1 sorbin and SH3 domain containing 1 ,0.001 0.74
*Fold change log2 format.
doi:10.1371/journal.pone.0014199.t007
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biological importance. This most likely reflects the fact that small
but coordinated changes in the expression of multiple genes within
a metabolic or biochemical pathway can work in concert to have
important effects [53]. A GO term analysis revealed over-
representation of genes involved in the cell cycle and in
inflammatory processes, leading us to study these processes in
greater detail.
We identified a novel function of SRA to promote preadipocyte
entry into S-phase during mitotic clonal expansion early in
adipocyte differentiation, demonstrated both by overexpression in
ST2 cells and knockdown in 3T3-L1 cells (Figure 7). Mechanisms
may include SRA-induced suppression of p21Cip1 and p27Kip1
expression, and increased phosphorylation of Cdk1/Cdc2
(Figure 7). However, the effect of SRA on p21Cip1 and
p27Kip1 expression is biphasic: although SRA decreases expres-
sion of these CKIs during MCE, it increases their expression
toward late differentiation, when mature adipocytes terminally exit
the cell cycle. This suggests that SRA may play a role in exiting
from the cell cycle during late differentiation. It has been reported
that C/EBPa and PPARc up-regulate p21Cip1 expression in 3T3-
L1 cells [44,62], and up-regulation of p21Cip1 and p27Kip1 is
characteristic of preadipocytes becoming committed to terminal
differentiation. Thus, the late effects of SRA to induce expression
of these proteins might reflect coactivation of PPARc.
SRA increases insulin-stimulated glucose uptake and phosphor-
ylation of downstream targets Akt and FOXO1, as shown by
overexpression in ST2 adipocytes and knockdown in 3T3-L1
adipocytes (Figures 5). The fact that these effects also are observed
following SRA knockdown of already-differentiated 3T3-L1
adipocytes (Figure 9) suggests that they reflect the function of
SRA in mature adipocytes, rather than changes in the degree of
differentiation. Although C/EBPa is required for insulin-regulated
glucose uptake [63,64], SRA knockdown in already-differentiated
adipocytes did not decrease C/EBPa expression (Figure 9B) and
SRA does not appear to function as a C/EBPa coactivator
(Figure 1E). This suggests that the effect of SRA on glucose uptake
is not mediated via C/EBPa. Expression of PPARc and the
PPARc target gene FABP4 are also not altered by SRA
knockdown in mature 3T3-L1 adipocytes (Figure 9B). Thus,
SRA may enhance glucose uptake in adipocytes by interaction
with other, currently unknown factors. The ability of SRA to
regulate expression of genes related to inflammatory processes
may be important in its effects on insulin sensitivity, since
inflammation causes insulin resistance. For example, the repres-
sion of Tlr4, SOCS1 and SOCS3 expression by SRA may
contribute to the SRA-induced increase in insulin-stimulated
glucose uptake, as might the ability of SRA to induce the
expression of Sorbs1. The observation by GSEA that SRA and
TNFa regulate a common set of genes in opposite directions
further suggests an anti-inflammatory, insulin-sensitizing effect of
SRA. This is supported by the finding that SRA overexpression
inhibits the ability of TNFa to phosphorylate JNK, whereas SRA
knockdown enhances it (Figures 8–9).
Although SRA is a non-coding RNA coactivator for transcrip-
tion factors [26,29,30,31,34], expression of a more 59 extended
transcript can lead to production of a protein, SRAP, that also has
coactivator function [27,28]. Our SRA expression vector does not
encode SRAP; however, shSRA knockdown would be expected to
deplete SRAP protein as well as SRA RNA. Therefore, we cannot
rule out that SRA and SRAP together may contribute to the
effects on adipocyte biology described herein.
Finally, in situ hybridization assays reveal that SRA is
predominantly cytoplasmic (,90%) [65], suggesting that SRA
may have extra-nuclear effects. Although we have not explored
such putative effects, the ability of SRA to inhibit TNFa-mediated
JNK phosphorylation is one such possibility.
In summary, our studies indicate that SRA affects adipogenesis
and adipocyte function in multiple ways, including through the
coactivation of PPARc, promotion of S-phase entry during mitotic
clonal expansion, and regulation of expression of inflammatory
genes and signal transduction in response to insulin and TNFa.
Identifying such roles of SRA in adipogenesis and insulin
sensitivity thereby provides novel insight into the mechanisms
underlying adipocyte physiology and pathophysiology.
Materials and Methods
Cell culture, staining and reagents
JEG-3 cells were maintained in minimum essential medium
supplemented with 10% FBS with penicillin-streptomycin at 37uC
in 5% CO2. Mouse 3T3-L1 preadipocytes and human embryonic
kidney 293T cells were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% calf serum and penicillin-
streptomycin at 37uC in 10% CO2. Mouse marrow-derived ST2
cells were incubated at 37uCi n5 %C O 2 in a-minimal essential
medium supplemented with 10% FBS and penicillin-streptomycin.
Induction of 3T3-L1 or ST2 cell differentiation was achieved by
treatment of 2 day post-confluent cells (day 0) in media
supplemented with 10% FBS and a hormone cocktail containing
3-isobutyl-1-methylxanthine (0.5 mM), dexamethasone (1 mM),
and insulin (0.167 mM), denoted MDI. On day 2, the cells were
treated again with 0.167 mM insulin, and subsequently were refed
with growth media containing 10% FBS every 2 days. In some
studies, troglitazone (50 mM in dimethylsulfoxide) was added to
the hormone cocktail to achieve a final media concentration of
5 mM (MDIT). Lipid accumulation in adipocytes was visualized by
staining with Oil Red O. Briefly, differentiated adipocytes were
washed with phosphate buffered saline (PBS) and fixed with 10%
formaldehyde in PBS for 4 min. After two washes with water, cells
were stained for 1–2 hrs with Oil Red O working solution (0.3%
(wt/vol) in 60% isopropanol). The stain was aspirated and cells
were washed at least twice with water and photographed.
Recombinant mouse TNFa was purchased from R&D Systems,
Inc. (Minneapolis, MN) and was reconstituted in PBS containing
Figure 4. RT-qPCR analyses confirm expression changes of
genes related to insulin sensitivity in SRA overexpressing ST2
adipocytes. Total RNA was isolated from day 4 MDIT-differentiated
SRA overexpressing or empty vector control ST2 cells. Gene expression
was then analyzed by RT-qPCR and was normalized to the expression of
cyclophilin. Significance was determined by Student’s t-test compared
to each control. * P,0.05, **P,0.01. Experiments were repeated at least
three times with triplicate samples.
doi:10.1371/journal.pone.0014199.g004
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proteinswereobtained asindicated:PPARc (H-100,sc-7196and E-
8, sc-7273), C/EBPa (14AA, sc-61) and GAPDH (6C5, sc-32233)
from Santa Cruz Biotechnology (Santa Cruz, CA); FABP4 (Cat#
MAB1443) from R&D Systems, Inc.; p21Cip1 (Cat# 556430),
p27Kip1 (Cat# 610241), pY15-Cdk1/Cdc2 (Cat# 612306) and
Cdk1/Cdc2 (Cat# 610037) from BD Transduction Laboratories
(San Jose, CA); phospho-Akt (Ser473) (Cat# 9271), phospho-Akt
(Thr308) (Cat# 9275), Akt (Cat# 9272), phospho-FOXO1
(Ser256) (Cat# 9461), FOXO1 (C29H4) (Cat# 2880), phospho-
SAPK/JNK (Thr183/Tyr185) (81E11) and SAPK/JNK (56G8)
from Cell Signaling Technology (Danvers, MA), and adiponectin
(Cat# A6354) from Sigma (Saint Louis, MO).
Plasmids, transfection, retroviral infection and reporter
gene assays
The vector pGEX-KG [66] was used to express human PPARc1
protein as a glutathione S-transferase (GST) fusion in Escherichia coli.
To maximize the recovery of full-length protein, the construct was
further tagged with six histidines at its C-terminus. For simplicity,
we refer to this protein as GST-PPARc. Deletion mutants of GST-
PPARc were constructed by inverse PCR and are depicted in
Figure 1A. PPARc was expressed in mammalian cells from the
vector pFlag-CMV-7.1 (Sigma). Mouse RXRa was expressed from
the vector pCDM. The reporter plasmid pPPRE-luc (a gift from
Amy Au, Kolling Institute of Medical Research, St. Leonards,
Australia) contains three copies of the acyl-CoA oxidase PPAR
Figure 5. SRA increases insulin-stimulated glucose uptake and phosphorylation of Akt and FOXO1 in mature adipocytes. A, ST2
preadipocytes infected with empty vector pMSCV (control) or pMSCV-SRA were differentiated with MDIT. On day 5 of differentiation, adipocytes were
serum-starved for 3 h and insulin-stimulated glucose uptake was quantified using 2-deoxy-D-[
14C]glucose. Data were normalized to total protein, and
results are presented as fold change compared to basal levels without insulin treatment. Data are given as the mean 6 S.D. Statistical significance
was evaluated with Student’s t-test: * p,0.05 and ** p,0.01. B, ST2 control (pMSCV) and SRA overexpressing (pMSCV-SRA) ST2 preadipocytes were
differentiated as in A. At the end of day 4 of differentiation, adipocytes were serum-starved for 12 h, cells were then treated without or with 10 nM
insulin for 10 min. Total cell lysates were subjected to immunoblotting (IB) with anti-phospho-Akt and phospho-FOXO1 antibodies as indicated. The
membrances were then stripped and reprobed with antibodies for total Akt and FOXO1. C, A similar experiment of insulin-stimulated glucose uptake
was performed on day 11 of differentiation by MDIT in 3T3-L1 cells infected with retroviruses expressing either a control shRNA (shControl) or an
shRNA against SRA (shSRA). D, Control (shControl) and SRA knockdown (shSRA) 3T3-L1 preadipocytes were similarly differentiated as in C. Cells were
serum-starved for 12 h, and then treated without or with 10 nM insulin for 20 min. Similar immunoblottings to B were performed with antibodies as
indicated. These results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0014199.g005
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isoform 2 expression vector pSCT-SRA was kindly provided by R.
Lanz (Baylor College of Medicine, Houston, TX). The leptin
promoter-luciferase reporter plasmid pObluc-760 (a gift from M.
DanielLane,JohnHopkinsUniversity,Baltimore,MD)andthep42
C/EBPa expression plasmid were as previously described [68]. To
create the retroviral expression vector pMSCV-SRA, pSCT-SRA
was linearized with EcoRI and partially digested with BamHI. The
SRA cDNA was gel purified and ligated to pMSCV [69] that had
been digested with BglII and EcoRI.
Transient transfections and luciferase reporter gene assays were
performed as described previously [34]. For retroviral infection,
293T cells were transfected by calcium phosphate coprecipitation
with pMSCV or pMSCV-SRA retroviral expression vectors and
viral packing vectors SVe-E-MLV-env and SVy-E-MLV as
described previously [39]. Virus-containing media were collected
16 h after transfection and passed through a 0.45-um syringe filter.
Polybrene was added to a final concentration of 8 mg/ml. The
media were then applied to subconfluent (40%) ST2 cells in 10-cm
plates. The infection protocol was repeated every 8–16 h until the
cells were 80% confluent. The cells were then trypsin-treated and
replated in a-minimal essential medium supplemented with 10%
FBS, penicillin-streptomycin and 3 mg/ml puromycin for selection.
GST fusion protein purification and in vitro RNA binding
assay
The purification of GST- PPARc and mutant versions from E.
coli strain BL21 by sequential cobalt and glutathione agarose
column chromatography, as well as the in vitro RNA binding assay,
were performed essentially as described [29]. The
32P-labeled
RNA SRA probe was made by in vitro transcription using T7 RNA
polymerase and [a-
32P]UTP from pSCT-SRA that had been
linearized by digestion with PvuII.
Gene silencing by short hairpin RNA (shRNA)
Knockdown of endogenous SRA in 3T3-L1 preadipocytes was
performed by infection with a retrovirus expressing either of two
shRNAs targeting SRA. Two different 21-nt shRNA constructs
targeting mouse SRA1 mRNA were designed using Invitrogen’s
web design. The sense oligonucleotides were: shSRA-1 59
GGCACTGCTAGTGCAAGAACT 39, and shSRA-2 59 GAC-
CACTGCAAGATCACTTGT 39. The oligonucleotides were
cloned into the retroviral pSUPERIOR.retro.puro vector (Oli-
goEngine, Seattle, WA) with a sense-loop-antisense design, using
the loop sequence CTTCCTGTCA. The sense oligonucleotide
included a BglII-compatible overhang at its 59 end, and the
antisense oligonucleotide similarly contained a HindIII-compatible
overhang. The oligonucleotides (250 pmol each) were annealed in
10 mM Tris (pH 7.5) and 100 mM NaCl (50 ml) with conditions of
95uC for 3 min, then 25 cycles of 20 seconds with a 1uC
decrement per cycle, 70uC for 10 minutes and then 65 cycles of 20
seconds with a 1uC decrement per cycle, then 4uC. Annealed
oligonucleotides were ligated into the pSUPERIOR.retro.puro
vector that had been digested with BglII and HindIII and gel
purified. Ligation was performed using 1 ml of the annealed
oligonucleotide mix, 75 ng of digested vector, T4 DNA ligase and
1X ligation buffer in a 10 ml reaction. Ligation was performed at
conditions of 100 cycles of 22uC for 20 seconds and 12uC for 1
minute. The ligation mix was transformed into competent E. coli
DH5a. Purified plasmids were sequenced to verify the correct
insert. The non-targeting shRNA control was as described [34].
Endogenous SRA in 3T3-L1 mature adipocytes was knocked
down by infection with a lentivirus expressing shRNA directed
against SRA. Briefly, the vector pLentiLox3.7-shSRA that
expresses shRNA-2 for SRA (targeting sequence as described
above) was constructed by inserting pairs of annealed DNA
oligonucleotides into the pLentiLox3.7-GFP vector between the
Hpal and Xho1 restriction sites [70]. 293T cells were cotrans-
fected with either shRNA (pLentiLox3.7-shSRA) or control
(pLentiLox3.7-GFP) plasmids and the packaging plasmids
psPAX2 and pMD2.G by the calcium phosphate method to
produce the lentivirus. The virus-containing media were collected,
passed through 0.45 mm filters, supplemented with 8 mg/ml
Polybrene (Sigma) and used to infect day 6 mature 3T3-L1
Figure6.RT-qPCRanalysesconfirmexpressionchanges ofSRAresponsivecellcyclerelated genes.TotalRNAwasisolatedfromday4MDIT-
differentiated SRA overexpressing or empty vector control ST2 cells. Similarly, total RNA was isolated from day 8 MDIT-differentiated 3T3-L1 SRA
knockdown (shSRA) orcontrol (shControl) adipocytes.Geneexpressionwas thenanalyzed byRT-qPCR,normalizedtocyclophilin.Significanceofdataw a s
determined by Student’s t-test compared to each control. * P,0.05, **P,0.01. Experiments were repeated at least three times with triplicate samples.
doi:10.1371/journal.pone.0014199.g006
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MDI at day 0. The 293T cell media were replaced with fresh
media, and were subsequently used to repeat the 3T3-L1 cell
infection two additional times at intervals of 8 to 12 h. The shSRA
or control lentivirus infected adipocytes were cultured until day 11,
at which time experiments were performed to evaluate insulin
stimulated glucose uptake and signal transduction in response to
insulin and TNFa.
Glucose uptake assay
Day 4 ST2 or day 8 to 11 3T3-L1 adipocytes were incubated
for 3 h in serum- and glucose-free media. Basal and insulin-
induced glucose uptakes were measured by rinsing the cells and
then incubating in serum- and glucose-free media for 30 min with
or without insulin, followed by the addition of unlabeled 2-deoxy-
D-glucose (920 mM) and 1 mCi of 2-deoxy-D-[
14C] glucose
(Amersham Biosciencess/GE Healthcare). After incubation for
5 min at room temperature, the media were removed, and the
cells were washed in cold PBS and lysed in 750 ml of 0.1% SDS.
The radioactivity associated with 250 ml was determined by liquid
scintillation counting. The results were corrected for nonspecific
binding using control cells incubated in the presence of 20 mM
cytochalasin B. Glucose uptake was normalized to protein content
as measured from the remaining cell lysate with Bio-Rad protein
reagent.
Cell lysis, immunoblotting and RNA-protein
immunoprecipitations
Cells were lysed in buffer containing 40 mM HEPES, 120 nM
sodium chloride, 10 mM sodium pyrophosphate, 10 mM sodium
glycerophosphate, 1 mM EDTA, 50 mM sodium fluoride, 0.5 mM
sodium orthovanadate, and 1% Triton X-100. Cell lysates were
gently resuspended by triteration and incubating at 4uC with gentle
rocking for 40 min to 1 h, followed by microcentrifugation for
10 min at 4uC. The supernatants were transferred to new tubes and
proteinconcentrationsweredetermined.Proteinswereseparatedby
SDS-PAGE and transferred onto polyvinylidene difluoride mem-
branes, and immunoblotting was performed using the antibodies
described above. Detection was with a SuperSignal West Dura kit
(Thermo Fisher Scientific, Rockford, IL) and a Bio-Rad Fluor-S
Max Multi-Imager.
To test whether SRA binds to PPARc in adipocytes, an RNA-
protein immunoprecipitation was performed as described previously
[34] with minor modifications. Briefly, day 8 3T3-L1 adipocytes were
washed twice with PBS, then chemical cross-linking of RNA and
protein was performed by addition of 0.1% formaldehyde for 10
minutes. After the addition of 0.25 M glycine, the cells were
harvested and lysed in RIPA buffer containing complete protease
inhibitor cocktail (Roche, Indianapolis, IN) and RNase inhibitor
(40 U/ml RNasin [Promega, Madison, WI]) and followed by
Table 8. Genes associated with the GO terms Mitotic cell cycle and DNA replication initiation that have significantly altered
expression in SRA overexpressing ST2 cells.
Probe set Symbol Gene name p-value Fold change*
Mitotic Cell cycle
1419431_at Ereg epiregulin ,0.001 22.34
1424278_a_at Birc5 baculoviral IAP repeat-containing 5 ,0.001 22.26
1452954_at Ube2c ubiquitin-conjugating enzyme E2C ,0.001 22.23
1450920_at Ccnb2 cyclin B2 ,0.001 22.21
1424046_at Bub1 budding uninhibited by benzimidazoles 1 homolog (S. cerevisiae) ,0.001 22.08
1452242_at Cep55 centrosomal protein 55 ,0.001 21.99
1416076_at Ccnb1-rs1 cyclin B1, related sequence 1 ,0.001 21.97
1417911_at Ccna2 cyclin A2 ,0.001 21.93
1416309_at Nusap1 nucleolar and spindle associated protein 1 ,0.001 21.84
1416802_a_at Cdca5 cell division cycle associated 5 ,0.001 21.77
1416664_at Cdc20 cell division cycle 20 homolog (S. cerevisiae) ,0.001 21.32
1417457_at Cks2 CDC28 protein kinase regulatory subunit 2 ,0.001 21.31
1455081_at Txnl4b thioredoxin-like 4B 0.001 0.43
1452798_s_at Mapk1ip1 mitogen activated protein kinase 1 interacting protein 1 0.001 0.49
1422477_at Cables1 Cdk5 and Abl enzyme substrate 1 ,0.001 0.55
1417850_at Rb1 retinoblastoma 1 ,0.001 0.6
DNA replication initiation
1415945_at Mcm5 minichromosome maintenance deficient 5, cell division cycle 46 (S.
cerevisiae)
,0.001 21.94
1438852_x_at Mcm6 minichromosome maintenance deficient 6 (MIS5 homolog, S. pombe)
(S. cerevisiae)
,0.001 21.8
1420028_s_at Mcm3 minichromosome maintenance deficient 3 (S. cerevisiae) ,0.001 21
1436708_x_at Mcm4 minichromosome maintenance deficient 4 homolog (S. cerevisiae) 0.003 20.81
1424143_a_at Cdt1 chromatin licensing and DNA replication factor 1 0.001 20.75
1456280_at Clspn claspin homolog (Xenopus laevis) ,0.001 20.74
*Fold change log2 format.
doi:10.1371/journal.pone.0014199.t008
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with DNase I (Ambion, Austin, TX) for 30 min at 37uC, and then
20 mM EDTA was added to stop the enzyme activity. Next, cell
lysates were diluted 1:10 with RIPA buffer containing nonspecific
yeast tRNA (100 mg/ml) and were precleared by incubation with
protein A beads (Millipore, Billerica, MA) for 30 min to 1 h at 4uC.
For immunoprecipitation, 3 mg of either normal IgG or anti-PPARc
(H-100 or E-8) were added to the precleared supernatants and
incubated at 4uCovernightwithgentlerocking.Thelysateswerethen
incubated with 50 ml protein A beads containing 5% BSA, protease
inhibitor cocktail and RNasin for 2–3 h at 4uC. The beads were
pelleted, washed 5 times with high-stringency RIPA buffer, and the
cross-links were reversed for 45 min at 70uC in reversal buffer as
described [34]. RNA was finally isolated by phenol-chloroform-
isoamyl alcohol extraction and ethanol precipitation containing
glycogen(Ambion),andwasusedforfirst-strandcDNAsynthesiswith
SuperScript III (Invitrogen, Carlsbad, CA) and random hexamer
primers. Real-time PCR was done using 2 ml of the resulting cDNA
Table 9. Genes associated with the GO term inflammatory response that have significantly decreased expression in SRA
overexpressing ST2 cells.
Probe set Symbol Gene name p-value Fold change*
Inflammatory response
1420380_at Ccl2 chemokine (C-C motif) ligand 2 ,0.001 22.84
1421228_at Ccl7 chemokine (C-C motif) ligand 7 ,0.001 22.36
1416676_at Kng1 kininogen 1 ,0.001 22.12
1438658_a_at Edg3 endothelial differentiation, sphingolipid G-protein-coupled receptor, 3 ,0.001 21.72
1425663_at Il1rn interleukin 1 receptor antagonist ,0.001 21.58
1419209_at Cxcl1 chemokine (C-X-C motif) ligand 1 ,0.001 21.5
1455747_at Ggtla1 gamma-glutamyltransferase-like activity 1 ,0.001 21.46
1450876_at Cfh complement component factor h ,0.001 21.45
1422758_at Chst2 carbohydrate sulfotransferase 2 ,0.001 21.15
1425985_s_at Masp1 mannan-binding lectin serine peptidase 1 ,0.001 21.09
1434376_at Cd44 CD44 antigen ,0.001 21.06
1460302_at Thbs1 thrombospondin 1 0.001 20.99
1424041_s_at C1s complement component 1, s subcomponent ,0.001 20.95
1417009_at C1r complement component 1, r subcomponent ,0.001 20.93
1450945_at Prkca protein kinase C, alpha ,0.001 20.91
1417268_at Cd14 CD14 antigen 0.001 20.66
1449147_at Chst1 carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 0.002 20.66
1419132_at Tlr2 toll-like receptor 2 ,0.001 20.65
1423954_at C3 complement component 3 ,0.001 20.63
1448460_at Acvr1 activin A receptor, type 1 0.001 20.62
1418930_at Cxcl10 chemokine (C-X-C motif) ligand 10 0.005 20.56
1449874_at Ly96 lymphocyte antigen 96 0.001 20.54
1452985_at Uaca uveal autoantigen with coiled-coil domains and ankyrin repeats 0.001 20.53
1418163_at Tlr4 toll-like receptor 4 0.003 20.47
1418099_at Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b 0.001 20.43
1460436_at Ndst1 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 0.002 20.39
*Fold change log2 format.
doi:10.1371/journal.pone.0014199.t009
Figure 7. SRA promotes preadipocyte entry into S-phase during mitotic clonal expansion and regulates cell cycle-related proteins.
A, Day 0 growth arrested SRA overexpressing or control ST2 preadipocytes (left), and SRA knockdown (shSRA) or shControl 3T3-L1 preadipocytes
(right), were induced by MDIT. Every two hours post-induction, cells were fixed and stained with propidium iodide, and the percentage of cells in
each phase of the cell cycle (G1, S, G2/M) was determined by FACS. The results are expressed as means and SDs for triplicate assays. Significance of
SRA overexpression or knockdown compared to controls was determined by Student’s t-test. P,0.05, **P,0.01. B, On day 0 before and day 1 (24 h)
after induction, cell number was determined by Coulter counter, and the cell numbers relative to day 0 control set at 1 were plotted. Significance was
determined by Student’s t-test. * P,0.05. C, SRA overexpression down-regulates CDK inhibitors p21Cip1 and p27Kip1 in ST2 preadipocytes during
MCE, but up-regulates their expression late in differentiation. Cell lysates were prepared from ST2 preadipocytes or adipocytes with SRA
overexpression or control cells as indicated during the time course of differentiation with MDIT. Immunoblotting was performed for p21Cip1,
p27Kip1, and GAPDH as a loading control. D, Similar to C except 3T3-L1 preadipocytes with endogenous SRA knockdown (shSRA) or control
(shControl) were studied. The phosphorylation of CDK1/Cdc2 at Tyr-15 also was studied by immunoblotting during early MCE. These results are
representative of at least three independent experiments.
doi:10.1371/journal.pone.0014199.g007
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signal obtained using primers that amplify cyclophilin.
Cell cycle analysis and BrdU labeling
Growth-arrested ST2 or 3T3-L1 preadipocytes, before or every
2 hr after induction with hormone cocktail MDIT, were harvested
by trypsinization, washed twice in PBS and fixed with cold 50%
EtOH for a minimum of 20 min. Fixed cells were washed with PBS
and incubated in the dark for at least 30 min with 50 mg/ml
propidiumiodide(PI)and100 mg/mlRNaseAinPBS.Labeled cells
were analyzed using a FACSCalibur flow cytometry system (BD
Biosciences, San Jose, CA) and cell cycle profiles were determined
using ModFit software (Becton Dickinson, San Diego, CA).
For BrdU labeling, SRA overexpressing or control ST2
preadipocytes were plated on chamber coverglass slides and
maintained in the ST2 cell media described above until one day
after confluence was achieved. Cells were induced to differentiate
with MDIT, and 10 h after induction were labeled for 4 h with
20 mM BrdU. The cells were fixed for 1 min in fresh 1:1
methanol:acetone, blocked 1 h at room temperature in blocking
buffer [34], incubated with anti-BrdU mouse monoclonal primary
antibody (1:500) (Calbiochem, La Jolla, CA, Cat# NA61) in
blocking buffer overnight at 4uC, and then incubated with FITC-
conjugated goat anti-mouse IgG (H+L) at 1:200 (AnaSpec, Inc.,
San Jose, CA) in blocking buffer for 2 h at room temperature. The
cell nuclei were stained with 1:20,000 Hoechst 33342 for 5 min at
Figure 8. SRA opposes TNFa signaling and inhibits TNFa-induced phosphorylation of JNK. A–B, GSEA was performed on MDIT-
differentiated ST2 cells that overexpress SRA versus empty vector control ST2 cells. A, Genes in the gene set NEMETH_TNF_UP are repressed by SRA
overexpression. B, Genes in the gene set TNFALPHA_ADIP_DN are induced by SRA overexpression. A and B show the relative expression levels of
genes with significantly altered expression displayed as heat maps and as enrichment plots. C and D, SRA inhibits TNFa-induced phosphorylation of
JNK. C, Day 4 SRA-overexpresing or control ST2 adipocytes were treated without or with TNFa (20 ng/ml) as indicated. Cell lysates were
immunoblotted for phospho-JNK (P-JNK). The membrane was stripped and reprobed for total JNK. D, Similar to C except the cells were day 8 SRA
knockdown (shSRA) or control (shControl) 3T3-L1 adipocytes. These results are representative of at least three independent experiments.
doi:10.1371/journal.pone.0014199.g008
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times with PBS. Finally, anti-fade reagent (ProLong Gold,
Invitrogen) was added to the monolayers and coverslips were
mounted on the slides. Microscopy was carried out using an
Olympus BX-51A fluorescent microscope at a magnification of
640. The percentage of BrdU positive cells was calculated by
comparing the number of BrdU labeled cells with the total number
of cells using ImageJ software [71].
Affymetrix microarray analysis
Gene expression profiling was performed to compare SRA
overexpressing (pMSCV-SRA) versus control (pMSCV vector)
ST2 adipocytes (day 4), or endogenous SRA knockdown
(pSuperior-shSRA-2) and control (pSuperior-shcontrol) 3T3-L1
adipocytes (day 8). Total RNA was extracted from the above fully
(MDIT) differentiated adipocytes with Trizol reagent (Invitrogen)
and cleaned up by RNeasy spin column (Qiagen Cat# 74104).
Figure 9. Knockdown of endogenous SRA in mature 3T3-L1 adipocytes confirms that SRA increases insulin action and inhibits TNFa
signaling. 3T3-L1 preadipocytes were differentiated under standard hormone cocktail induction (MDI). Day 6 mature adipocytes were infected with
lentivirus expressing control (pLentiLox3.7-GFP) or SRA knockdown shRNA (pLentiLox3.7-shSRA), and then were cultured to day 11. A, Efficiency of
SRA knockdown was determined by RT-qPCR in day 11 3T3-L1 mature adipocytes. RNA expression was normalized to cyclophilin mRNA. B, Left panel,
day 11 control or SRA knockdown adipocytes were stained with Oil Red O to assess lipid accumulation; right panel, mRNA expression for adipocyte
marker genes was assessed by RT-qPCR. C, Insulin-stimulated glucose uptake was assayed in day 11 3T3-L1 mature adipocytes, as described in
Figure 5. D, Effects of SRA knockdown on insulin dependent phosphorylation of Akt and FOXO1 (upper panel), and TNFa dependent phosphorylation
of JNK (lower panel), as described in Figures 5 and 8, respectively. Data are given as the mean 6 S.D. Statistical significance was evaluated with
Student’s t test: * p,0.05 and ** p,0.01. These results are representative of two independent experiments.
doi:10.1371/journal.pone.0014199.g009
SRA in Adipocyte Biology
PLoS ONE | www.plosone.org 18 December 2010 | Volume 5 | Issue 12 | e14199Biotin-labeled cRNAs were prepared according to the Affymetrix
GeneChip Expression Analysis Technical Manual. Hybridizations
were performed on GeneChip mouse Genome 430 2.0 arrays
(Affymetrix). To check the overall quality of the raw data, several
quality control plots were made before the statistical analysis for
significant changes of gene expression. One plot showed the
distribution of perfect match probe intensities to confirm their
consistency for each chip and the other looked at similarities in the
RNA degradation between samples to help ensure differences in
gene expression could not be attributed to differences in
degradation. The expression values (log2 transformed data) were
then calculated using a robust multi-array average (RMA) [72].
This is a modeling strategy that converts the perfect match probe
value into an expression value for each gene. As a final quality
control step we performed a principle component analysis and
plotted the first two principle components to show that replicated
samples were grouping together. The microarray data have been
deposited in the Gene Expression Omnibus (accession number
GSE21594).
Prior to making comparisons, we filtered probsets based on a
variance over all samples of 0.05. This removed those probesets
that were unchanged in any sample, which were by definition not
interesting to us. After filtering there were 19068 of 45101
probesets that remained.
We then fitted a linear model to the data that was specifically
designed for microarray analysis [73] using the limma package of
Bioconductor in the R statistical environment. This was almost
identical to fitting a t-statistic to each probeset, but by first fitting a
linear model we were able to determine if a particular comparison
was significant while still accounting for the significance of the
same comparison in the other cells line (e.g. testing if ST2 SRA
overexpression vs. control is significant when 3T3-L1 SRA
knockdown vs. control is already known to be significant). This
modeling strategy also helped us to increase power to detect
differences in two ways. First, the denominator of the t-statistic,
which estimates the variance of the comparison, is known to be less
accurate when there is not much replication. Here we used an
overall variance estimate from all probesets to increase the
accuracy of the observed variance for each comparison. Second,
the denominator of a contrast was based on the variance of all the
samples rather than just those under consideration. This increased
the number of samples used to compute the variance, which
tended to increase our power to make correct decisions.
Furthermore, we selected probesets based on an adjusted p-value
of 0.05, adjusted using Benjamini Hochberg false discovery rate
(FDR) [74].
Gene ontology (GO) analysis was performed for the genes
(probesets) with significant changes (p,0.05). The GOstats
package of Bioconductor was used to test the association between
Gene Ontology terms and the gene list [75]. This was done using a
conditional hypergeometric test; conditioning means that each
term was tested for statistical overrepresentation after removing
genes that overlapped a significant child term. The gene universe
was defined as all genes on the array after a nonspecific filter
removed genes with a variance over all samples less than .05.
Gene set enrichment analysis (GSEA) was performed as
described [53]. All of the gene sets examined were obtained from
the Molecular Signature Database C2, which includes 1892
metabolic and signaling pathways derived from 12 publicly
available and manually curated databases.
To confirm expression level changes of mRNAs altered by
either SRA overexpression or knockdown, reverse transcription-
real time PCR (RT-qPCR) was performed. Briefly, total RNA
from ST2 or 3T3-L1 adipocytes was isolated with Trizol reagent.
Four mg of total RNA were reverse transcribed using SuperScript
III and qPCR was performed as described previously [34]. Primer
sequences for each SRA responsive gene used for RT-qPCR
analysis are provided in Table S9.
Supporting Information
Figure S1 SRA effects on adipocyte differentiation and gene
expression. A, Control (pMSCV empty vector; Cont.) or SRA
overexpressing ST2 cells were grown to confluence and treated
with FBS, MDI or MDIT to induce adipocyte differentiation. On
day 4 of differentiation, cells were stained with Oil Red O to
identify triacylglycerol droplets. B, 3T3-L1 preadipocytes were
infected with retroviruses expressing either a control short hairpin
RNA (shControl) or one of two shRNAs directed against mouse
SRA (shSRA-1 or -2). Preadipocytes were induced to differentiate
with MDI or MDIT. At day 8, adipocytes were stained with Oil
Red O. C, Control and SRA overexpressing ST2 adipocytes
differentiated by MDIT were analyzed at day 4 by RT-qPCR for
the expression of C/EBPa, PPARc, FABP4 and adiponectin,
normalized to cyclophilin. D, shControl and shSRA-2 3T3-L1
adipocytes differentiated by MDIT were analyzed at day 8 by RT-
qPCR for the expression of C/EBPa, PPARc, FABP4 and
adiponectin, normalized to cyclophilin. E, Whole cell extracts
from shControl and shSRA-2 3T3-L1 adipocytes differentiated by
MDIT at day 8 were subjected to immunoblotting for PPARc or
C/EBPa. The membranes were stripped and reprobed for
GAPDH as a loading control. These results are representative of
at least three independent experiments.
Found at: doi:10.1371/journal.pone.0014199.s001 (2.70 MB TIF)
Figure S2 Confirmation of SRA effect on S-phase entry during
preadipocyte mitotic clonal expansion by BrdU incorperation. A,
Immunocytochemistry demonstrates an increase in BrdU positive
SRA overexpressing ST2 preadipocytes, versus empty vector
control ST2 preadipocytes. The cells were exposed to BrdU 10–
14 hours post-induction by MDIT. B, Quantification of the data
from B, showing a significant increase in fraction of BrdU positive
cells in SRA overexpressing ST2 preadipocytes, confirming an
increase in S-phase cells (2500 nuclei from random fields were
counted per construct); **p , 0.01 by Student’s t-test. Experi-
ments were repeated at least three times with triplicate samples.
Found at: doi:10.1371/journal.pone.0014199.s002 (1.35 MB TIF)
Figure S3 RT-qPCR analyses confirm expression changes of
SRA responsive inflammatory genes in ST2 adipocytes. Total
RNA was isolated from day 4 MDIT-differentiated SRA
overexpressing or empty vector control ST2 cells. Gene expression
was then analyzed by RT-qPCR, normalized to cyclophilin.
Significance was determined by Student’s t-test compared to each
control. * P , 0.05, **P , 0.01 and *** p , 0.001. Experiments
were repeated at least three times with triplicate samples.
Found at: doi:10.1371/journal.pone.0014199.s003 (0.28 MB
TIF)
Table S1 GO terms in biological processes (BP) overrepresented
amongst genes with altered expression in SRA overexpressing
versus empty vector control ST2 adipocytes.
Found at: doi:10.1371/journal.pone.0014199.s004 (0.08 MB
DOC)
Table S2 GO terms in molecular function (MF) overrepresented
amongst genes with altered expression in SRA overexpressing
versus empty vector control ST2 adipocytes.
Found at: doi:10.1371/journal.pone.0014199.s005 (0.05 MB
DOC)
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amongst genes with altered expression in endogenous SRA
knockdown versus control 3T3-L1 adipocytes.
Found at: doi:10.1371/journal.pone.0014199.s006 (0.05 MB
DOC)
Table S4 GO terms in molecular function (MF) overrepresented
amongst genes with altered expression in endogenous SRA
knockdown versus control 3T3-L1 adipocytes.
Found at: doi:10.1371/journal.pone.0014199.s007 (0.04 MB
DOC)
Table S5 Down-regulated gene sets by SRA overexpression in
ST2 cells analyzed by GSEA
Found at: doi:10.1371/journal.pone.0014199.s008 (0.22 MB
DOC)
Table S6 Up-regulated gene sets by SRA overexpression in ST2
cells analyzed by GSEA.
Found at: doi:10.1371/journal.pone.0014199.s009 (0.04 MB
DOC)
Table S7 Down-regulated gene sets by SRA knockdown in 3T3-
L1 cells analyzed by GSEA.
Found at: doi:10.1371/journal.pone.0014199.s010 (0.05 MB
DOC)
Table S8 Up-regulated gene sets by shSRA knockdown in 3T3-
L1 cells analyzed by GSEA.
Found at: doi:10.1371/journal.pone.0014199.s011 (0.21 MB
DOC)
Table S9 Primers used in real time PCR.
Found at: doi:10.1371/journal.pone.0014199.s012 (0.05 MB
DOC)
Data Set S1
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Data Set S2
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